(CALGB 90601) A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Transitional Cell Carcinoma
Description: 

The purpose of this study is to compare the effects of the combination of the chemotherapy drugs gemcitabine and cisplatin (chemotherapy) with the combination of gemcitabine, cisplatin and the experimental drug bevacizumab on transitional cell cancer.

Study Number: 

NCG 186610

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT00942331

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.